Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986;57(2):117-25.
doi: 10.1007/BF00381379.

Influence of chronic low-level exposure to lead on plasma immunoglobulin concentration and cellular immune function in man

Influence of chronic low-level exposure to lead on plasma immunoglobulin concentration and cellular immune function in man

I Kimber et al. Int Arch Occup Environ Health. 1986.

Abstract

The immunological status of individuals occupationally exposed to low levels of inorganic lead has been examined and compared with that of non-exposed, age and sex-matched controls. At the time of testing the exposed population had a mean (+/- SD) blood lead concentration of 38.4 +/- 5.6 micrograms X 100 ml-1 (n = 39) compared with a mean value of 11.8 +/- 2.2 micrograms X 100 ml-1 (n = 21) for the control group. No differences in the serum concentrations of IgG, IgA and IgM between the populations were observed and there existed no correlation between blood lead concentration and serum immunoglobulin levels. In addition assessment was made of the capacity of peripheral blood mononuclear cells to respond to the mitogen phytohaemagglutinin (PHA), a correlate of T cell function, and to spontaneously lyse cells of the erythroleukaemic cell line K562, a measure of NK cell function. In neither case was there a difference between exposed and control populations and no correlation between reactivity and blood lead concentration. Although previous studies in rodents have indicated that exposure to inorganic lead resulting in similar blood lead concentrations may compromise immune competence our data suggest that no similar effect occurs in man.

PubMed Disclaimer

References

    1. Toxicol Appl Pharmacol. 1983 Jun 30;69(2):272-5 - PubMed
    1. Int J Cancer. 1979 Feb;23(2):143-7 - PubMed
    1. Science. 1971 Jun 4;172(3987):1031-2 - PubMed
    1. Int J Immunopharmacol. 1980;2(4):269-79 - PubMed
    1. Scand J Clin Lab Invest Suppl. 1968;97:77-89 - PubMed

LinkOut - more resources